1
|
O'Mahoney N, Alfarsi A, O'Sullivan H, McSweeney S, Crean A, Fitzpatrick D. Sounding out stability of enteric coated dosage forms using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS). Int J Pharm 2021; 602:120614. [PMID: 33887391 DOI: 10.1016/j.ijpharm.2021.120614] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2020] [Revised: 04/11/2021] [Accepted: 04/13/2021] [Indexed: 10/21/2022]
Abstract
Stability testing is essential in the pharmaceutical industry to determine product shelf- life and the conditions under which drug products should be stored. Stability testing involves a complex set of procedures, considerable cost, time, and scientific expertise to build quality, efficacy and safety in a drug formulation. This paper highlights a new complementary approach to stability testing called Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS). BARDS measurements are based on reproducible changes in the compressibility of a solvent during dissolution. It is monitored acoustically via associated changes in the frequency of induced acoustic resonances. This study presents a novel approach to track the change of various drug formulations to determine the formulation's stability. Pellets, tablet and multiple-unit pellet system (MUPS) formulations were investigated to examine the effect of polymer coating and formulation core degradation over time. In combination with minimal usage of Ultra Violet - Visible Spectroscopy, BARDS can effectively track these changes. The technique offers a rapid approach to characterizing pharmaceutical formulations. BARDS can enable rapid development of solid drug formulation dissolution and disintegration testing as an In-Process Control test and drug stability analysis. The data show that a solid oral dose formulation has an intrinsic acoustic signature specific to the method of manufacture, excipient composition and elapsed time since the production of a product. BARDS data are also indicative of which aspect of a formulation may be unstable, whether a coating, sub-coating or core. It is potentially a time-efficient, cost-effective and greener approach to testing coating stability, disintegration and overall formulation stability.
Collapse
Affiliation(s)
- Niamh O'Mahoney
- School of Chemistry, University College Cork, Cork, Ireland; Analytical and Biological Chemistry Research Facility (ABCRF), University College Cork, Cork, Ireland
| | - Anas Alfarsi
- School of Chemistry, University College Cork, Cork, Ireland; Analytical and Biological Chemistry Research Facility (ABCRF), University College Cork, Cork, Ireland
| | | | - Seán McSweeney
- Cork Institute of Technology, Cork, Ireland; BARDS Acoustic Science Labs, Bio-Innovation Centre, UCC, Cork, Ireland
| | - Abina Crean
- School of Pharmacy, University College Cork, Cork, Ireland
| | - Dara Fitzpatrick
- School of Chemistry, University College Cork, Cork, Ireland; Analytical and Biological Chemistry Research Facility (ABCRF), University College Cork, Cork, Ireland; BARDS Acoustic Science Labs, Bio-Innovation Centre, UCC, Cork, Ireland.
| |
Collapse
|
2
|
The encapsulation of hydroxytyrosol-rich olive oil in Eudraguard® protect via supercritical fluid extraction of emulsions. J FOOD ENG 2021. [DOI: 10.1016/j.jfoodeng.2020.110215] [Citation(s) in RCA: 11] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
3
|
Zhong L, Gao L, Li L, Zang H. Trends-process analytical technology in solid oral dosage manufacturing. Eur J Pharm Biopharm 2020; 153:187-199. [DOI: 10.1016/j.ejpb.2020.06.008] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2020] [Revised: 06/11/2020] [Accepted: 06/14/2020] [Indexed: 10/24/2022]
|
4
|
O'Mahoney N, Keating JJ, McSweeney S, Hill S, Lawrence S, Fitzpatrick D. The sound of tablets during coating erosion, disintegration, deaggregation and dissolution. Int J Pharm 2020; 580:119216. [PMID: 32165222 DOI: 10.1016/j.ijpharm.2020.119216] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2020] [Revised: 03/05/2020] [Accepted: 03/07/2020] [Indexed: 11/28/2022]
Abstract
This research aims to address a gap in our understanding of the mechanisms by which pharmaceutical tablets achieve highly reproducible and predictable drug release. The present industrial and regulatory practice is centred around tablet dissolution, i.e. what follows disintegration, yet the vast majority of problems that are found in formulation dissolution testing can be traced back to the erratic disintegration behaviour of the medicinal product. It is only due to the distinct lack of quantitative measurement techniques for disintegration analysis that this situation arises. Current methods involve costly, and time-consuming test equipment, resulting in a need for more simple, green and efficient methods which have the potential to enable rapid development and to accelerate routine solid drug formulation dissolution and disintegration testing. In this study, we present a novel approach to track several sequential tablet dissolution processes, including coating erosion, disintegration, deaggregation and dissolution using Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS). BARDS, in combination with minimal usage of UV spectroscopy, can effectively track these processes. The data also show that a solid oral dose formulation has an intrinsic acoustic signature which is specific to the method of manufacture and excipient composition.
Collapse
Affiliation(s)
- Niamh O'Mahoney
- Department of Chemistry, Analytical and Biological Chemistry Research Facility (ABCRF), University College Cork, Ireland
| | - John J Keating
- Department of Chemistry, Analytical and Biological Chemistry Research Facility (ABCRF), University College Cork, Ireland; School of Pharmacy, University College Cork, Ireland
| | - Seán McSweeney
- BARDS Acoustic Science Labs, Bio-Innovation Centre, UCC, Ireland
| | - Sam Hill
- GlaxoSmithKline R&D, Pharmaceutical Development & Supply, Ware, UK
| | - Simon Lawrence
- GlaxoSmithKline R&D, Pharmaceutical Development & Supply, Ware, UK
| | - Dara Fitzpatrick
- Department of Chemistry, Analytical and Biological Chemistry Research Facility (ABCRF), University College Cork, Ireland; BARDS Acoustic Science Labs, Bio-Innovation Centre, UCC, Ireland.
| |
Collapse
|